SCAP and hypertriglyceridemia: Furthermore, silencing Scap with siRNA reduced all 3 nuclear SREBPs, preventing fatty liver and hypertriglyceridemia in sucrose‐fed hamsters.52 In our study, NTM attenuated not only fatty liver but also its attendant inflammation (steatohepatitis) by normalizing its inflammatory biomarkers (elevated levels of the liver transaminases ALT and AST in plasma) and reducing phosphorylated NFκB RelA (p65) in liver cell nuclei (Figure 3D and 3E).